How to Apply for a Grant

print  Print this page

LUNGevity Awards for Translational Research

LUNGevity supports research in three tracks: career development, early detection, and targeted therapeutics. At this time, we are soliciting applications for Career Development Awards.


Career Development Awards

  • 3-year grants, totaling $300,000
  • Limit of one award per institution

Mark the dateLetter of Intent Deadline:

FEBRUARY 17, 2016

Apply

Career Development Awards

LUNGevity’s Career Development Awards for Translational Research program was created to support future research leaders who will keep the field of lung cancer research vibrant with new ideas.

Applicants must be within the first five years of their faculty appointment. The Career Development Awards are mentored awards; a mentoring plan is part of the required submission.

Projects that will be funded in 2016 are expected to have a direct impact on the early detection of lung cancer or on the outcomes of lung cancer, or to provide a clear conceptual or experimental foundation for the future development of methods for early detection and/or individualized treatment, including through immuno-oncology.

Early Detection Awards

LUNGevity’s Early Detection Awards for Translational Research support research projects directed at new approaches to improved clinical methods for the detection and diagnosis of primary tumors. Projects are expected to have a direct impact on the early detection and/or diagnosis of lung cancer or a clear conceptual or experimental foundation for the future development of methods for early detection. We are evaluating the structure of our Early Detection Awards Program for maximum impact. Information on our next Early Detection Award RFA will be posted at a later date.

Targeted Therapeutics Awards

LUNGevity’s Targeted Therapeutics Awards for Translational Research support research projects directed at targeted therapeutics, including immuno-oncology, that will make a difference in the clinical treatment and survival of patients. We are evaluating the structure of our Targeted Therapeutics Awards Program for maximum impact. Information on our next Therapeutics Award RFA will be posted at a later date.